Login to Your Account



AIMS TO DOUBLE REVENUES BY 2018

Merck renews commitment to China market with plans for $107M plant

By Shannon Ellis
Staff Writer

Wednesday, July 30, 2014

SHANGHAI – Merck KGaA, of Darmstadt, Germany, has reiterated its commitment to China, forging ahead with its €80 million (US$107.3 million) manufacturing plant, expected to be Merck's second largest globally and its first such pharmaceutical investment in China.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription